Emmaus Medical, Inc. develops and manufactures pharmaceutical-grade L-glutamine oral powder for the treatment of sickle cell disease.

Emmaus Medical, Inc.

Emmaus Life Sciences, Inc | 8,811 followers on LinkedIn. Improving the lives of people with rare disease. | Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan disease.  We are initially focusing our product development efforts in Sickle Cell Disease, a genetic disorder.  Our lead product candidate is an oral pharmaceutical grade L-glutamine treatment that demonstrated positive clinical results in our completed Phase 3 clinical trial for sickle cell anemia and sickle ß0-thalassemia.

CEO at Emmaus Life Sciences / Emmaus Medical

Willis Lee

Rare Disease - Hematology/Oncology, Product Launch, Key Account Management

Traci Evitts

Strategic Account Manager - Rare Disease/ Hematology / Oncology

Richard O'Neal

National Director, Community Engagement Pharmaceuticals Rare Diseases, USA Orphan Drug - Nurse Practitioner Hematology/Oncology

Karen Gant, PhDc APRN FNP-BC

Emmaus Life Sciences, Inc

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 16, 2024 2:18 AM	179d815d
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 16, 2024 2:18 AM	f28e4fa4
crunchbase trigger	general	Nov 16, 2024 2:18 AM	e7a4d3ea
crunchbase profile	general	Nov 16, 2024 2:42 AM	145d725c
li profile	general	Nov 16, 2024 2:18 AM	36610301
translate crunchbase fundingrounds	general
peers	general	Nov 16, 2024 2:18 AM	37f863ab
news basic	general	Nov 16, 2024 2:18 AM	12c12aca
bundesanzeiger	filings
financials download nd	financials
private financials	financials

EMMA

COM:EMMAUSMEDICAL

Emmaus Medical, Inc.